Cargando…
00002 Translational Fellows as a mechanism to improve throughput of university technology commercialization
ABSTRACT IMPACT: This work aims to identify best practices for university-based asset development programs to improve commercialization throughput, which in turn will drive innovation in the biomedical space and directly contribute to improved human health. OBJECTIVES/GOALS: University technology tr...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827677/ http://dx.doi.org/10.1017/cts.2021.515 |
_version_ | 1784647684205838336 |
---|---|
author | Hall, Everett G. Krenning, Tom M. Kinch, Michael S. |
author_facet | Hall, Everett G. Krenning, Tom M. Kinch, Michael S. |
author_sort | Hall, Everett G. |
collection | PubMed |
description | ABSTRACT IMPACT: This work aims to identify best practices for university-based asset development programs to improve commercialization throughput, which in turn will drive innovation in the biomedical space and directly contribute to improved human health. OBJECTIVES/GOALS: University technology transfer exhibits a high rate of failure, often due to a lack of researcher experience or early-stage financial capital. The LEAP program at Washington University (WUSTL) was created to address these needs. The goal of this study is to assess the performance of LEAP against similar gap funds and further improve program operations. METHODS/STUDY POPULATION: The goals of LEAP are achieved by providing university inventors with individualized consulting and feedback from industry experts, as well as awarding funding to the most promising projects. To determine whether these activities are impactful, we distributed an awardee report form to collect data on all funded LEAP projects, and then combined the results with project registration information. We also collected records Office of Technology Management, including invention disclosures, licenses, and startup creations. The resulting dataset was used to calculate program metrics and then evaluated against comparable gap funds. Sentiment data from participant surveys were also analyzed to assess perceived program value and knowledge transfer. RESULTS/ANTICIPATED RESULTS: As of the Sp2020 cycle, LEAP has funded 76 projects. Resubmitted projects had a funding rate of 52%, vs. 34% for new projects. Of the startups founded off of WUSTL intellectual property since 2016, nearly two-thirds had previously participated in LEAP. Funded LEAP projects also had a 29% licensing rate, which is comparable to similar gap funds. Lastly, participants self-reported an increase in knowledge across a range of commercialization areas. DISCUSSION/SIGNIFICANCE OF FINDINGS: The increased repeat funding rate and self-reported knowledge suggest that LEAP is impactful in building commercialization proficiency. The licensing rate and prevalence of LEAP projects in WUSTL startups also indicate that LEAP is indeed promoting tech transfer. Together, these results suggest that LEAP could be a model for other institutions. |
format | Online Article Text |
id | pubmed-8827677 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Cambridge University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-88276772022-02-28 00002 Translational Fellows as a mechanism to improve throughput of university technology commercialization Hall, Everett G. Krenning, Tom M. Kinch, Michael S. J Clin Transl Sci Commercialization/Entrepreneurship ABSTRACT IMPACT: This work aims to identify best practices for university-based asset development programs to improve commercialization throughput, which in turn will drive innovation in the biomedical space and directly contribute to improved human health. OBJECTIVES/GOALS: University technology transfer exhibits a high rate of failure, often due to a lack of researcher experience or early-stage financial capital. The LEAP program at Washington University (WUSTL) was created to address these needs. The goal of this study is to assess the performance of LEAP against similar gap funds and further improve program operations. METHODS/STUDY POPULATION: The goals of LEAP are achieved by providing university inventors with individualized consulting and feedback from industry experts, as well as awarding funding to the most promising projects. To determine whether these activities are impactful, we distributed an awardee report form to collect data on all funded LEAP projects, and then combined the results with project registration information. We also collected records Office of Technology Management, including invention disclosures, licenses, and startup creations. The resulting dataset was used to calculate program metrics and then evaluated against comparable gap funds. Sentiment data from participant surveys were also analyzed to assess perceived program value and knowledge transfer. RESULTS/ANTICIPATED RESULTS: As of the Sp2020 cycle, LEAP has funded 76 projects. Resubmitted projects had a funding rate of 52%, vs. 34% for new projects. Of the startups founded off of WUSTL intellectual property since 2016, nearly two-thirds had previously participated in LEAP. Funded LEAP projects also had a 29% licensing rate, which is comparable to similar gap funds. Lastly, participants self-reported an increase in knowledge across a range of commercialization areas. DISCUSSION/SIGNIFICANCE OF FINDINGS: The increased repeat funding rate and self-reported knowledge suggest that LEAP is impactful in building commercialization proficiency. The licensing rate and prevalence of LEAP projects in WUSTL startups also indicate that LEAP is indeed promoting tech transfer. Together, these results suggest that LEAP could be a model for other institutions. Cambridge University Press 2021-03-30 /pmc/articles/PMC8827677/ http://dx.doi.org/10.1017/cts.2021.515 Text en © The Association for Clinical and Translational Science 2021 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Commercialization/Entrepreneurship Hall, Everett G. Krenning, Tom M. Kinch, Michael S. 00002 Translational Fellows as a mechanism to improve throughput of university technology commercialization |
title | 00002 Translational Fellows as a mechanism to improve throughput of university technology commercialization |
title_full | 00002 Translational Fellows as a mechanism to improve throughput of university technology commercialization |
title_fullStr | 00002 Translational Fellows as a mechanism to improve throughput of university technology commercialization |
title_full_unstemmed | 00002 Translational Fellows as a mechanism to improve throughput of university technology commercialization |
title_short | 00002 Translational Fellows as a mechanism to improve throughput of university technology commercialization |
title_sort | 00002 translational fellows as a mechanism to improve throughput of university technology commercialization |
topic | Commercialization/Entrepreneurship |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8827677/ http://dx.doi.org/10.1017/cts.2021.515 |
work_keys_str_mv | AT halleverettg 00002translationalfellowsasamechanismtoimprovethroughputofuniversitytechnologycommercialization AT krenningtomm 00002translationalfellowsasamechanismtoimprovethroughputofuniversitytechnologycommercialization AT kinchmichaels 00002translationalfellowsasamechanismtoimprovethroughputofuniversitytechnologycommercialization |